Oncology Research and Treatment

Article	Citations
Follow-Up Time of Anal Cancer Screening among Women Living with HIV at High Risk of Developing Anal Cancer	28
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023	26
uGI: Biomaker-Cut-Offs in der Immunonkologie	23
Front & Back Matter	18
PharmaNews	11
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab	10
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience	9
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study	9
Society Bulletins	8
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis	8
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease	8
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study	8
Career and Professional Development for Young Oncologists	7
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?	7
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem	7
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center	7
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial	7
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine	6
PharmaNews	6
Society Bulletins	6
OnkoImmun 21	6
Front & Back Matter	5
PharmaNews	5
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany	5
PharmaNews	5

DKK 2024: Acalabrutinib im Praxis-Check	5
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer	5
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz	5
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report	5
Capivasertib/Fulvestrant bei ER+/HER2– MBC	4
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology	4
PharmaNews	4
Society Bulletins	4
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors	4
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial	4
Vorwort des DGHO-Vorstands	4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality	4
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative	4
Erratum	4
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients	4
PharmaNews	4
Epcoritamab: Indikationserweiterung für das FL	4
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models	3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie	3
Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines	3
Oncology in Europe	3
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL	3
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer	3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM	3
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer	3
Perspectives for Cancer Care and Research in Central and Eastern Europe	3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%	3
Management of Advanced Penile Cancer	3
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi	3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen	3
Society Bulletins	3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer	3
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 Investigation	3
Guidelines of Onkopedia: What Is New?	2
Front & Back Matter	2
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study	2
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey	2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines	2
Front & Back Matter	2
PharmaNews	2
Acknowledgement to Reviewers	2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review	2
Society Bulletins	2
Society Bulletins	2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich	2
PharmaNews	2
Contents Vol. 47, 2024	2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie	2
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy	2

OnkoImmun 19	2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment	2
Management of Patients Undergoing CAR-T Cell Therapy in Germany	2
Erweiterte Therapieoptionen bei EGFRm NSCLC	2
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers	2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy	2
Prelims	2
OnkoImmun 18	1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission	1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis	1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC	1
PharmaNews	1
Prelims	1
Society Bulletins	1
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review	1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries	1
Society Bulletins	1
Prognostic Significance of HER2 Positivity in Endometrium Cancer	1
Onkologische Patient*innen individuell behandeln und begleiten	1
Prelims	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies	1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study	1
Society Bulletins	1
A Population-Based and Propensity Score-Matched Investigation of the Occurrence, Management, and Prognosis of Anal Mucinous Adenocarcinoma Patients	1
Society Bulletins	1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review	1
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel	1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast	1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database	1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment	1
Front & Back Matter	1
Society Bulletins	1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres	1
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis	1
Moving Tumor-Agnostic Therapy to the Big Stage: Translational and Molecular Oncology Highlights from the ESMO Congress 2025	1
Society Bulletins	1
PharmaNews	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022	1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–2018	1
Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer	1
PharmaNews	1
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer	1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma	1
Effektive Therapieoption: Pegcetacoplan bei PNH	0
Society Bulletins	0
Society Bulletins	0
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network	0
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts	0
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians	0
Neu bei mCRPC: Talazoparib + Enzalutamid	0
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis	0
Safety of Surgery within 24 h following Colonoscopy for Colorectal Cancer: A Retrospective Propensity Scores Matched Analysis	0
PharmaNews	0
PharmaNews	0
PharmaNews	0
Momelotinib bei Myelofibrose und Anämie	0
4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC	0
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer:	0
Treatment of Advanced or Metastatic Urothelial Cancer	0
Lungenkarzinom: Aktuelle Entwicklungen zur Therapie	0
PharmaNews	0
Before-and-after Studies in Oncology: How Real Is the Real-World Evidence?	0
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice	0
Society Bulletins	0
What Is New in the German S3 Guideline on Gastric Cancer: Diagnosis, Staging, and Treatment	0
Society Bulletins	0
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis	0
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Report	0
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Geriatric Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024	0
PharmaNews	0
2025 ASCO Bladder Cancer Highlights	0
Prelims	0
Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation	0
TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma	0
The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade	0
New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas	0
Society Bulletins	0
Gender as a Contextual Factor in Quality of Life of Cancer Survivors: A Literature Review	0

Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group	0
Highlights from ESMO 2024 as a Young Head and Neck Oncologist	0
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism	0
Front & Back Matter	0
Paraneoplastic Papillitis as a Precursor to Colon Carcinoma: A Case of Unexpected Vision Loss Leading to Early Cancer Detection	0
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas	0
Safety and preliminary activity of neoadjuvant trastuzumab deruxtecan (T-DXd) plus 5-fluorouracil and folinic acid for HER2-positive, resectable esophagogastric adenocarcinoma: Results from the safety	0
Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?	0
Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates	0
Managing Antithrombotic Treatment in Patients with Immune Thrombocytopenia	0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers	0
Osimertinib: Hohe Wirksamkeit im Zentralnervensystem	0
Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?	0
Erstmals 3-Jahres-Daten bei biliären Karzinomen	0
Society Bulletins	0
Resektabilität bei NSCLC III: Schlüssel zur Therapie	0
mNSCLC - Leitlinie empfiehlt POSEIDON-Regime	0
Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement	0
The Role of Regulatory Policies in Shaping Outpatient Cancer Treatment in Germany: A Comparative Perspective	0
Society Bulletins	0
Real-World-Evidenz für Daratumumab-CyBorD bei AL-Amyloidose	0
Supportive Therapie bei Krebs: AGSMO Jahreskongress 2025, 24. Mai 2025, Berlin und online – Abstracts	0
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells	0
Onkopedia: What’s New? Systemic Tumor Treatment in Pregnancy	0
Use of Follow-Up Psycho-Oncology Consultations in Urological Cancer after Transition from Inpatient to Outpatient Care	0
The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvan	0
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case	0
Melflufen: Therapieoptionen beim Multiplen Myelom	0
Systematic Evaluation of Vitamin D and the Risk of Breast Cancer Development	0
A Real-World Evaluation of Brain Imaging in Patients with Advanced Non-Small Cell Lung Cancer: Insights from a German Claims Data Analysis	0
Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients	0
Machine Learning-Based Prognostic Modeling of Seven Signatures Associated with Lysosomes for Predicting Prognosis and Immune Status in Clear Cell Renal Cell Carcinoma	0
PharmaNews	0
Albert Schweitzer, Chronic Myeloid Leukemia, and War	0
Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic	0
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database	0
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany	0
Treatment Satisfaction and Treatment Wishes of Patients with Chronic Cancer-Related Pain	0
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases	0
Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells – Insights from Healthy Donors Compared to Gastric Cancer Patients	0
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome	0
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review	0
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review	0
PharmaNews	0
Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review	0
The Path to Clinical Implementation of DPYD Pharmacogenetic Testing: Long-Term Experience from an External Quality Assessment Provider and a University Testing Center	0
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom	0
Stereotactic Radiotherapy for Penile Metastasis: Case Report and Systematic Literature Review	0
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors – Results from the PROSa Study	0
PharmaNews	0
Prelims	0
The Critical Role of Sex and Gender in Medicine	0
Fortgeschrittenes oder nicht resezierbares HCC: explorative 4-Jahres-Analyse STRIDE	0
Retraction Statement	0
Treatment Navigation in Breast Cancer Management: Process Cost Analysis Based on German Case Studies	0
Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2− Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial	0
Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer	0
Abemaciclib beim eBC und mBC	0
Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma	0
Vorteile des MAIA-Regimes bei Hochrisikozytogenetik	0
A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors	0
Society Bulletins	0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review	0
r/r DLBCL: Heilungschance mit Axi-Cel	0
PharmaNews	0
Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021	0
Frontline Pembrolizumab or Methotrexate in Elderly, Frail, or Cisplatin-Ineligible Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of the Randomized Phase 2	0
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany	0
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy	0
Durvalumab-Immuntherapie: Dauer beeinflusste Erfolg	0
Effectiveness and Safety of Combining Transarterial Chemoembolization with Tyrosine Kinase and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Meta-Analysis	0
PharmaNews	0
Molecular Tissue Profiling in a Clinically Selected Pancreatic Cancer Cohort	0
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)	0
PharmaNews	0
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation	0
Quality of Life and Patient-Reported Outcomes: Highlights from the European Society for Medical Oncology Annual Meeting Congress 2025	0
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data	0
PharmaNews	0
Chemoimmuntherapie als ein Standard bei ED-SCLC	0
Society Bulletins	0
KRAS Inhibition in Non-Small Cell Lung Cancer with Central Nervous System Involvement: Current Evidence and Future Directions	0
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatin	0
(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary – Highlights from ESMO 2025 and the First International Cancer of Unknown Primary Meeting	0
Verlässliche Immuntherapie in der Versorgungsrealität	0
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer	0
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem-Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer Centers	0
Anti-HER2/Neu Antibody Therapy Inhibits HER2 + Breast Cancer by Blocking Myeloid-Derived Suppressor Cell Activity	0
PharmaNews	0
Management of Advanced Germ Cell Tumours	0
Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update	0
Society Bulletins	0
Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie	0
Society Bulletins	0
In Memoriam: Prof. Dr. med. Wolfgang Queisser	0